Pneumonia Testing Market Size, Share, Key Players, Growth Trend, and Forecast, 2030

Posted by sneha j on September 21st, 2022

Pneumonia is a type of lung infection caused by bacteria, such as the Streptococcus pneumonia virus, fungi, and parasites. In pneumonia, the air sacs of the lungs called alveoli are filled with fluid or pus that causes inflammation. The symptoms of pneumonia include short breathing, fever, chest pain, nausea & vomiting. However, these clinical symptoms overlap with many other diseases, such as asthma, bronchitis, and the common cold, making it difficult to diagnose pneumonia. Physicians recommend tests such as blood tests, sputum tests, pleural fluid cultures, and pulse oximetry tests to confirm the onset of pneumonia.

Download Sample Report:

This disease is most prevalent in South Asia and African countries. The key factors that drive Pneumonia Testing Market Growth include an increase in technological advancement in pneumonia testing systems, such as the development of enhanced nucleic acid detection tests and advancement in point of care (POC) tests.

Moreover, an increase in awareness toward early diagnosis and a rise in government expenditures on healthcare fuel the market growth. However, the limited detection capability & accuracy of some of the pneumonia testing products and regulatory & economic hurdles hamper the market growth. Conversely, the surge in the adoption of molecular diagnostic testing and high untapped market potential in developing countries are anticipated to provide lucrative growth opportunities for the market.

The Pneumonia Testing Industry is segmented on the basis of method, technology, type & end-user region. In terms of method, it is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables.  Based on technology, it is categorized into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on the end-user, it is classified into hospitals, diagnostic laboratories, home care, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The POC testing segment was the major contributor to the market in 2020, due to multiple benefits offered by this technique, such as technological advancements, ease of use, and rapid results. The analyzers segment is estimated to register the highest growth rate during the forecast period, owing to t their frequent usage for pneumonia tests from 2020–to 2030.

Polymerase chain reaction registered the highest growth rate in the forecast period among the different technologies, as this test can identify the causative agent and accurately detect pneumonia in patients. Among the end-user, the hospital occupied the major share of the pneumonia testing market in 2021, due to a large number of patients suffering from pneumonia across the world.

Region-wise the Pneumonia Testing Market Analysis is done across North America, Europe, Asia-Pacific, and LAMEA, in 2020, North America accounted for the maximum Pneumonia Testing Market Share in 2020, owing to the rise in prevalence of pneumonia and a surge in technological advancements in various pneumonia testing products. However, Asia-Pacific is projected to grow at the highest CAGR during the forecast period, owing to an increase in investments by major companies in R&D activities.

Get Detail Report


Like it? Share it!

sneha j

About the Author

sneha j
Joined: July 12th, 2022
Articles Posted: 104

More by this author